
Sign up to save your podcasts
Or


An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
See omnystudio.com/listener for privacy information.

91,061 Listeners

22,000 Listeners

78,307 Listeners

43,566 Listeners

14,336 Listeners

407 Listeners

2,166 Listeners

424 Listeners

1,382 Listeners

965 Listeners

112,394 Listeners

56,439 Listeners

192 Listeners

15,544 Listeners

3,300 Listeners

16,238 Listeners

6,210 Listeners

67 Listeners

31 Listeners

4 Listeners

155 Listeners

58 Listeners

232 Listeners

229 Listeners

9,123 Listeners

61 Listeners

63 Listeners

83 Listeners

381 Listeners

22 Listeners

12 Listeners

986 Listeners

7 Listeners

2 Listeners

76 Listeners